Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBabcock Regulatory News (BAB)

Share Price Information for Babcock (BAB)

Share Price is delayed by 15 minutes
Get Live Data
1,035.00    -3.50 (-0.34%)
Bid:
1,036.50
Ask:
1,037.00
Spread: 0.50 (0.048%)
Market Cap: £5.06b
BAB Live PriceLast checked at - London Stock Exchange

Intraday Babcock Share Chart

Contract Award

18 Dec 2017 07:00

RNS Number : 5632Z
Babcock International Group PLC
18 December 2017
 

18 December 2017

 

Babcock International Group PLC (Babcock or the Group)

Cavendish Nuclear awarded contract to supply Sellafield

 

Babcock subsidiary Cavendish Nuclear, the UK's largest nuclear services business, has been awarded a 10-year contract to supply Sellafield Ltd with specialist handling and containment systems to process nuclear material.

 

Worth up to £95 million over the first three years, Cavendish Nuclear will meet all of Sellafield's requirements for the design, manufacture and supply of this complex bespoke equipment for the treatment and management of nuclear materials.

 

Virtual reality simulation will play a key part in delivering the contract. Once the preliminary design is complete, full-scale mock-ups with virtual reality headsets will allow the customer to test out the ergonomics and identify any modifications at the earliest possible stage.

 

Cavendish Nuclear specialises in the design, manufacture and delivery of services across the nuclear lifecycle and has extensive experience of working across Sellafield, including ongoing work on the design of remote-handling equipment for the product and residues treatment plant.

 

Cavendish Nuclear will use Babcock's Rosyth Dockyard, one of the UK's largest manufacturing facilities, for the project. Following recent major investment in new workshops, fabrication bays and remote overhead cranes, Rosyth has a proven track record of delivering large-scale complex products, including the containment doors for the pile fuel cladding silo at Sellafield.

 

Cavendish Nuclear and its partners will be supported by a supply chain located across the UK, bringing together the best of Britain's nuclear expertise in an integrated team committed to meeting the customer's demanding specification.

 

Babcock CEO Archie Bethel said:

 

"We are delighted that Cavendish Nuclear continues to support Sellafield in the delivery of this strategically important programme. The team will provide the significant manufacturing capacity the project needs, as well as opportunities to share best practice across the UK."

 

 

Ends

 

 

 

Enquiries

 

Babcock International Group PLC

020 7355 5300

Franco Martinelli

Kate Hill

FTI Consulting

020 3727 1340

Andrew Lorenz

Nick Hasell

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
CNTFFAFMIFWSELE
Date   Source Headline
15th Nov 20192:13 pmRNSType 31 Contract Win
25th Sep 20197:00 amRNSTrading Update
12th Sep 20197:00 amRNSPreferred bidder for UK naval frigate programme
11th Sep 20193:10 pmRNSUpdate on refinancing
11th Sep 20193:00 pmRNSPublication of Final Terms
27th Aug 20199:40 amRNSHolding(s) in Company
12th Aug 20191:11 pmRNSDirector/PDMR Shareholding
30th Jul 201910:00 amRNSHolding(s) in Company
18th Jul 20192:31 pmRNSResult of AGM
8th Jul 20191:37 pmRNSDirector/PDMR Shareholding
2nd Jul 20192:01 pmRNSPublication of a Prospectus
2nd Jul 201911:39 amRNSHolding(s) in Company
26th Jun 201910:08 amRNSDirector Declaration
19th Jun 20194:58 pmRNSDirector/PDMR Shareholding
17th Jun 20197:00 amRNSStatement regarding media speculation
14th Jun 20192:58 pmRNSDirector/PDMR Shareholding
13th Jun 20194:22 pmRNSNotice of AGM
7th Jun 20195:07 pmRNSHolding(s) in Company
7th Jun 201911:29 amRNSHolding(s) in Company
6th Jun 20193:29 pmRNSDirector/PDMR Shareholding
5th Jun 201911:26 amRNSDirector/PDMR Shareholding
5th Jun 201910:40 amRNSDirector/PDMR Shareholding
5th Jun 20197:00 amRNSCapital Markets Day
29th May 20191:07 pmRNSHolding(s) in Company
22nd May 20197:00 amRNSFull year results for the year ended 31 March 2019
21st May 20194:35 pmRNSPrice Monitoring Extension
16th May 20198:43 amRNSDirector Declaration
15th May 20192:06 pmRNSResponse to publication of anonymous report
7th May 20191:30 pmRNSHolding(s) in Company
29th Apr 201910:20 amRNSHolding(s) in Company
25th Apr 20194:51 pmRNSHolding(s) in Company
11th Apr 20199:21 amRNSHolding(s) in Company
3rd Apr 20197:00 amRNSDirectorate Change
13th Mar 20199:00 amRNSDevonport Site Visit
26th Feb 20197:00 amRNSTrading Update
18th Jan 201911:17 amRNSDirector/PDMR Shareholding
17th Jan 20193:55 pmRNSDirectorate Change
20th Dec 20189:52 amRNSDirector/PDMR Shareholding
12th Dec 201810:17 amRNSDirector/PDMR Shareholding
5th Dec 20184:53 pmRNSHolding(s) in Company
3rd Dec 20184:58 pmRNSHolding(s) in Company
3rd Dec 20187:00 amRNSJoint venture wins new Australian defence contract
30th Nov 20187:00 amRNSContract Win
22nd Nov 20182:02 pmRNSDirector/PDMR Shareholding
22nd Nov 20181:55 pmRNSDirector/PDMR Shareholding
22nd Nov 201810:06 amRNSDirector/PDMR Shareholding
21st Nov 201811:51 amRNSDirector/PDMR Shareholding
21st Nov 20187:00 amRNSHalf year report
20th Nov 201810:03 amRNSHolding(s) in Company
19th Nov 20187:00 amRNSClarification on Sky News report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.